NCT05921981

Brief Summary

This study aimed to compare the effectiveness of two interventions, white noise, and multisensory stimulation, during retinopathy examinations on premature infants. Retinopathy is a common eye disorder among premature infants, which can cause visual impairments if not addressed. The research used a randomized controlled experimental design, with premature infants randomly assigned to either the white noise or multisensory stimulation group or control group. Physiological responses, behavioral indicators, and the pain of the retinopathy examination were measured. Trained healthcare professionals conducted the investigations in a controlled environment, and statistical analyses were employed to compare the outcomes between the three groups. The findings of this study have the potential to inform the development of more effective and well-tolerated examination protocols for premature infants, leading to improved visual outcomes and overall well-being for this vulnerable population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 19, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 27, 2023

Completed
13 days until next milestone

Study Start

First participant enrolled

July 10, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

May 17, 2024

Status Verified

May 1, 2024

Enrollment Period

4 months

First QC Date

June 19, 2023

Last Update Submit

May 16, 2024

Conditions

Keywords

preterm infantsMultisensorial stimulationWhite Noise

Outcome Measures

Primary Outcomes (1)

  • Neonatal Pain

    The Premature Infant Pain Profile (PIPP) is a validated and widely used tool designed to assess pain in preterm infants. It takes into account physiological and behavioral indicators that are indicative of pain in this population. The PIPP scale includes the evaluation of facial expressions, gestational age, heart rate, oxygen saturation, and behavioral state to assess pain levels. Accordingly, the highest is 21 points and the lowest is 0 points. If the Premature Baby Pain Profile is between 0-6 points, the pain is considered mild, 7-12 points moderate, 13-21 points severe.

    first 30 minutes during procedure

Study Arms (3)

Multisensorial Stimulation Group

EXPERIMENTAL

The group to which multi-sensory stimulation will be applied during the retinopathy examination.

Behavioral: Multisensorial Stimulation

White Noise Group

ACTIVE COMPARATOR

The group to which White Noise will be applied during the retinopathy examination.

Behavioral: White Noise

Control Group

NO INTERVENTION

The group that will receive routine care during the retinopathy examination

Interventions

Multisensory stimulation in newborns involves the deliberate and simultaneous activation of multiple sensory modalities to provide sensory experiences that promote development and enhance learning. Newborns are naturally inclined to explore and make sense of their environment through their senses, including touch, sight, sound, taste, and smell.

Multisensorial Stimulation Group
White NoiseBEHAVIORAL

White Noise

White Noise Group

Eligibility Criteria

Age32 Months - 36 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Premature newborns with a gestational age of ≤ 32 weeks or newborns with a birth weight of \< 1500 g, according to the records.
  • Neonates undergoing a first-time eye exam to screen for retinopathy of prematurity.
  • Newborns with their mother.
  • Newborns who have not been fed in the last hour.

You may not qualify if:

  • Newborns who need cardiopulmonary resuscitation (CPR) during the exam.
  • Newborns experiencing apnea at the time of examination

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Akdeniz University

Antalya, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Retinal DiseasesRetinopathy of Prematurity

Condition Hierarchy (Ancestors)

Eye DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Halil İbrahim HI Taşdemir, PhD

    Burdur Mehmet Akif Ersoy University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 19, 2023

First Posted

June 27, 2023

Study Start

July 10, 2023

Primary Completion

November 20, 2023

Study Completion

January 1, 2024

Last Updated

May 17, 2024

Record last verified: 2024-05

Locations